Probiotics
Lactobacilli and Bifidobacteria
Balancing the intestinal ecosystem
Microbial numbers and the intestinal eocsystem
The vaginal microflora
Intestinal microflora in the newborn infant
How do probiotics work?
Mechanisms of action of probiotics
Effects of probiotics on the intestinal microflora
Custom probiotics CP-1: A highly effective probiotic
supplement
Probiotics play a key role in human nutrition and health in
balancing the intestinal microflora naturally. Probiotics
have been used therapeutically to modulate immunity, improve
digestive processes, lower cholesterol, treat rheumatoid arthritis,
prevent cancer, improve lactose intolerance, and prevent or
reduce the effects of atopic dermatitis, Crohn's disease,
ulcerative colitis, IBS, diarrhoea, constipation as well as
Candida and urinary tract infections.
Our probiotics are available in capsule and powder formulations
ranging from a minimum 25 billion probiotic bacteria per capsule
to 100-300 billion per gram for the powders at the time of
expiration, verified by independent laboratory testing.
Adult formulation CP-1 contains five superior strains of freeze-dried
probiotic microorganisms with a minimum total bacterial count
of 25 billion per capsule guaranteed at date of expiry, which
is usually one year after manufacture. These strains are L.
Acidophilus, L.Rhamnosus,L. Plantarum, B. Longum and B. Bifidum,
and are most specifically helpful to the small and large intestines.
To be effective we feel that a probiotic supplement should
have a high bacterial count and a blend of different genera.
Our latest independent laboratory test results indicate around
70 billion total bacterial count per capsule. This count is
much higher than claimed to be found in most probiotics products
on the market today.
Our CP-1 Acidophilus and Bifidus supplements are dairy
free, hypoallergenic, and do not contain any artificial colours,
flavours, preservatives, sugar, gluten or FOS. (All
FOS contain free sugar).
Each bottle of our CP-1 Acidophilus and Bifidus supplements
contains 90 capsules.
order this product
The term 'probiotic' is derived from the Greek, meaning ‘for
life’. Probiotics are currently defined as ‘live
microorganisms which, when consumed in adequate amounts, confer
a health benefit to the host’. Common descriptions for
probiotics include ‘friendly’, ‘beneficial’
or ‘healthy’ bacteria.
Probiotic bacteria are generally, though not exclusively,
lactic acid bacteria and include Lactobacillus acidophilus,
L. casei, L. bulgaricus, L. plantarum, L. salivarius, L. rhamnosus,
L. reuteri, Bifidobacterium bifidum, B. longum, B. infantis
and S. thermophilus. Probiotic bacteria are used in the production
of yogurt, various fermented milk products and dietary supplements.
LACTOBACILLI AND BIFIDOBACTERIA
Lactobacilli and Bifidobacteria are Gram-positive lactic acid-producing
bacteria that constitute a major part of the normal intestinal
microflora in animals and humans. These friendly bacteria
play a key role in enhancing resistance to colonization by
exogenous, potentially pathogenic organisms.
Lactobacilli are Gram-positive, non-spore forming rods or
coccobacilli. They have complex nutritional requirements and
are strictly fermentative, aerotolerant or anaerobic, aciduric
or acidophilic. Lactobacilli are found in a variety of habitats
where rich, carbohydrate-containing substrates are available,
such as human and animal mucosal membranes, on plants or material
of plant origin, sewage and fermenting or spoiling food.
Bifidobacteria constitute a major part of the normal intestinal
microflora in humans throughout life. They appear in the stools
a few days after birth and increase in number thereafter.
The number of bifidobacteria in the colon of adults is 1010
- 1011 CFU/gram, but this number decreases with age. Also
demographic differences affect the number and species of bifidobacteria.
Bifidobacteria are nonmotile, nonsporulating Gram-positive
rods with varying appearance. Most strains are strictly anaerobic.
B. longum may be considered as the most common species of
bifidobacteria, being found both in infant and adult faeces.
This species is closely related to B. infantis, which often
leads to identification problems.
BALANCING THE INTESTINAL ECOSYSTEM
The condition and function of the gastrointestinal tract is
essential to our well being. After the respiratory tract,
the GI tract constitutes the second largest body surface area,
comparable in surface area to a tennis court. During a normal
lifetime, about 60 tons of food will pass through this canal.
The human intestinal microflora is highly important to the
host for several reasons. Firstly, microflora benefit the
host by increasing resistance to new colonization as well
as by protecting against the overgrowth of already-present
potentially pathogenic organisms. Another function important
to the host is the high metabolic activity of the intestinal
flora. The extent of this activity has been claimed to be
similar to that of the liver. Administration of antimicrobial
agents, such as antibiotics, is the most common cause of disruption
of the balance of the normal microflora and leads to decreased
resistance to colonization ( known clinically as loss of colonisation
resistance), and to alterations in the metabolic activities
of the intestinal flora.
It is likely that the first scientific assessments of probiotics
were made in 1908, based on the work of the Russian Nobel
Prize Laureate Elie Metchnikoff. He first hypothesized that
a high concentration of lactobacilli in intestinal flora were
important for health and longevity in humans. Indeed, we now
know that intestinal flora plays an important role in health:
stimulating the immune system, protecting the host from invading
bacteria and viruses, aiding digestion and assimilation of
food. Yet, the importance of these bacteria in the gastro-intestinal
(GI) tract has been neglected for a long time, while the focus
was merely placed on enteric pathogens and other factors leading
to gastrointestinal "disorders".
The composition of the gastrointestinal flora differs among
individuals, and also throughout life within the same individual.
Many factors, such as diet or climate, ageing, medications
(especially antibiotics), illness, stress, pH, infection,
geographic location, race, socioeconomic circumstances, and
lifestyle can upset this balance. Interactions of typical
intestinal bacteria may also contribute to stabilization or
destabilization. A state of balance within the microbial population
within the GI tract can be called "eubiosis" while
an imbalance is termed "dysbiosis". For optimum
"gut flora balance", the beneficial bacteria, such
as the gram-positive Lactobacilli and Bifidobacteria, should
predominate, presenting a barrier to invading organisms. Around
85% of the intestinal microflora in a healthy person should
be good bacteria and 15% bad bacteria. The greater the imbalance,
the greater the likely symptoms. The use of probiotics may
be the most natural, safe and common sense approach for keeping
the balance of the intestinal ecosystem.
MICROBIAL NUMBERS AND THE INTESTINAL
ECOSYSTEM
The 25-35 foot long GI tract of an adult human is estimated
to harbour about 100 trillion viable bacteria. This is approximately
10 times the total number of cells in the human body. These
live bacteria account for around 2 lbs of a body's weight
and are known as intestinal or gut flora. Viruses, fungi and
protozoa can also be present, but these normally form only
a minor component of the total resident population of micro-organisms
in healthy individuals.
The density of micro-organisms in the gut flora increases
dramatically from 10-1,000 CFU/ml (Colony Forming Units basically
mean live bacteria) in the stomach to 10-100 billion CFU/gm
in the large intestine and these belong to as many as 400
different species. Anaerobic bacteria outnumber aerobic bacteria
by a factor of 1000:1. Anaerobic flora is dominated by Bacteroides
spp., bifidobacteria, propionibacteria and clostridia. Among
aerobic and anaerobic bacteria, enterobacteria, (mainly E.coli),
and enterococci predominate.
Bacteria have been estimated to constitute 35-50% of the volume
of the contents in the human colon. They profoundly influence
nutritional, physiologic and protective processes. Both direct
and indirect defensive functions are provided by the normal
microflora. Specifically, gut bacteria directly prevent colonization
by pathogenic organisms by competing for essential nutrients
or for epithelial attachment sites. By producing antimicrobial
compounds, volatile fatty acids, and chemically modified bile
acids, indigenous gut bacteria also create a local environment
that is generally unfavourable for the growth of enteric pathogens.
This phenomenon is called Colonization Resistance, which can
be defined as the ability of micro-organisms belonging to
the normal gut microflora to impede the implantation of pathogens.
This function of the microflora is also known as the barrier
effect. While probiotic bacteria improve colonization resistance,
consensus thinking is that the importance of lactic acid bacteria
as probiotic agents lies more in the indirect mechanisms such
as immunomodulation.
The normal or indigenous microflora of man consists of a resident
(autochtonous) part, which largely stays with the host organism,
and a transient part, which may dynamically change in composition.
This is not unique for man as it also applies to animals.
The turnover of the transient part of the microflora of the
digestive tract depends both on the composition of the resident
flora or Colonization Resistance, and on the degree of contamination
(both qualitatively and quantitatively) of ingested food and
beverages. Regarding the latter, hygienic conditions of the
environment are important.
The defence systems in the gut can be divided into three parts:
the gut flora, the gut mucosa and epithelium and the related
immune system.
The intestine, composed of villi and crypts, is coated with
mucus that protects the intestinal cells. At the bottom of
the crypts lie specialised cells known as Paneth cells that
are able to release antimicrobial molecules into the gut lumen.
The intestinal flora, present mainly in the colon, forms a
natural barrier to pathogens. The intestinal immune system
comprises cells disseminated beneath the epithelium and also
between epithelial cells (intraepithelial lymphocytes). Lymphocytes
are also found within more organised structures, lymphoid
follicles, with a central region of B lymphocytes and a lateral
region of T lymphocytes. Above these structures, we find M
cells, which are specialised in transporting particles to
the follicle. These areas of the intestine are known as Peyer's
patches. When a lymphocyte is activated by a dendritic cell
presenting an antigen, it leaves the mucosa in lymph and enters
the bloodstream via the thoracic canal. This activated lymphocyte
then colonises either the same mucosa or other mucosal effector
sites.
THE VAGINAL MICROFLORA
Although less complex than the gastrointestinal microflora,
the normal vaginal microflora of the premenopausal woman is
composed of a variety of bacterial species. Anaerobes are
most frequently isolated and appear in numbers of 107 - 109
CFU/ml of vaginal secretion. Lactobacillus spp. is the most
frequently isolated genus found in the highest numbers. They
play a role in maintaining the balance of the normal vaginal
flora by producing hydrogen peroxide. It has been shown that
approximately 70% of premenopausal, healthy women harbour
hydrogen peroxide-producing lactobacilli. Corynebacterium,
Staphylococcus and Bacteroides spp. are among the anaerobes
frequently isolated.
INTESTINAL MICROFLORA IN THE NEWBORN
INFANT
Foetuses are sterile in the womb, but beginning with the birth
process, infants are exposed to microbes that originate from
the mother and the surrounding environment including breast
milk or formula. The infant tends to acquire the flora swallowed
from the vaginal fluid at the time of delivery. Because vaginal
flora and intestinal flora are similar, an infant's flora
may closely mimic the intestinal flora of the mother.
Another factor affecting the intestinal flora of the newborn
is delivery mode. A normal vaginal delivery commonly permits
transfer of bacteria from the mother to the infant. During
caesarean deliveries, this transfer is completely absent.
These infants commonly acquire, and are colonized with, flora
from the hospital's environment and, therefore, their flora
may differ from maternal flora. Infants delivered by caesarean
section are colonized with more anaerobic bacteria, especially
Bacteroides, than vaginally delivered infants. Clostridium
perfringens is the anaerobic bacterium most frequently isolated
after caesarean deliveries. When colonized, caesarean delivered
infants less frequently harbour E. coli, and more often klebsiella
and enterobacteria.
The initial colonizing bacteria vary with the food source
of the infant. In breast-fed infants, Bifidobacteria account
for more than 90% of the total intestinal bacteria. The low
concentration of protein in human milk, the presence of specific
anti-infective proteins such as immunoglobulin A, lactoferrin,
lysozyme, and oligosacharides (prebiotics), as well as production
of lactic acid, cause an acid milieu and are the main reasons
for its bifidogenic characteristics. In bottle-fed infants,
Bifidobacteria are not predominant. Instead enterobacteria
and gram-negative organisms dominate because of a more alkaline
milieu and the absence of the prebiotic modulatory factors
present in breast milk.
The establishment of an intestinal microbial ecology is very
variable at the beginning but will become a more stable system
similar to the adult microflora by the end of the breastfeeding
period.
Other factors affecting the intestinal microflora of the infant
include geographical differences (industrialized vs. developing
countries) and administration of antibiotics in neonatal intensive
care.
HOW DO PROBIOTICS WORK?
Probiotics must be ingested regularly for any health promoting
properties to persist. It is possible to manipulate the composition
of the intestinal microflora in adults through dietary supplementation
with probiotics. This concept is gaining popularity throughout
the world.
The mode of action of a probiotic may include host microflora
modulation, (by improvement of the microbial balance via interaction
of orally applied viable microbes with the microflora in the
digestive tract lumen), the modulation of host metabolic activities,
(by stabilizing digestive enzyme pattern), and immunomodulation,
(by activation and regulation of mucosa-associated and systemic
immune system responses). These modes of action are also strain-dependent.
The intestinal microflora provides protection against a broad
range of pathogens, including certain forms of Clostridia,
Escherichia Coli, Salmonella, Shigella and Pseudomonas, as
well as yeasts such as Candida albicans.
MECHANISMS OF ACTION OF PROBIOTICS
Antimicrobial Effects of Probiotics.
| A. |
Modify microflora
to suppress pathogens. |
| B. |
Secrete antibacterial substances.
Probiotic bacteria produce a variety of substances that
are inhibitory to both gram-positive and gram-negative
bacteria. These include organic acids, hydrogen peroxide
and bacteriocins. These compounds may reduce not only
the number of viable pathogenic organisms but may also
affect bacterial metabolism and toxin production. This
occurs through reduction of luminal pH through the production
of volatile short-chain fatty acids, mainly acetates,
propionates and butyrates. And of course, through production
of lactic acid (Bifidobacterium, Lactobacillus, Streptococcus),
leading to a reduction in colonic pH. |
| C. |
Compete with pathogens to prevent
their adhesion to the intestine. |
| D. |
Compete for nutrients necessary
for pathogen survival |
| E. |
Antitoxin effect |
Effect of Probiotics on the Intestinal Epithelium
| A. |
Promote tight contact
between epithelial cells forming a functional barrier. |
| B. |
Reducing the secretory and inflammatory consequences
of bacterial infection. |
| C. |
Enhancing the production of defensive molecules such
as mucins. |
Immune Effects of Probiotics
| A. |
Probiotics acting
as vehicles to deliver anti-inflammatory molecules to
the Intestine. |
| B. |
Enhance signalling in host cells to reduce inflammatory
response. |
| C. |
Switch in immune response to reduce allergy. |
| D. |
Reduce the production of inflammatory substances. |
EFFECTS OF PROBIOTICS ON THE INTESTINAL
MICROFLORA
Probiotics modulate the composition of the intestinal microflora.
The survival of ingested probiotics in different parts of
the gastrointestinal tract differs between strains. As a result
of their concentration in the lumen, they contribute to transient
modulation of the microflora ecology, at least during the
period of intake. This specific change may be seen in the
GI tract for a few days after the start of consumption of
the probiotic preparation, depending on the dosage of the
strain in question. Results show that with regular consumption,
the bacteria temporarily colonise the lower intestine. Once
consumption stops, the number of probiotic microorganisms
quickly falls. This applies to all probiotic supplements available
in the market today.
Many studies have demonstrated significant shifts in bacterial
counts in human faeces following consumption of specific probiotic
strains, generally resulting in increased numbers of health-promoting
genera (Lactobacillus and Bifidobacterium) and decreased numbers
of potentially harmful ones (such as several strains of Clostridum,
Enterococcus and Candida). These studies, however, reflect
the bacteriological situation in faecal matter only and do
not provide an accurate picture of the situation in different
parts of the gastrointestinal tract or in the mucosal layer
of the gut. Furthermore, many species of intestinal bacteria
from faecal samples cannot be cultured on specific plates.
Probiotic bacteria modulate the metabolic activity of the
gut flora. Probiotics, being able to lower the pH in the intestinal
tract, may thus be able to interfere with the enzymatic activity
of the flora.
Custom Probiotics CP-1: A HIGHLY EFFECTIVE PROBIOTIC
SUPPLEMENT
Qualities of an effective probiotic dietary supplement include
the following:
1) Must be of human origin
2) Exert a beneficial effect on the host
3) Be non-pathogenic and non-toxic
4) Contain a large number of viable cells
5) Be capable of surviving and metabolizing in the gut
6) Remain viable during storage and use
7) Be antagonistic to pathogens.
Our custom probiotic formulations meet all these requirements.
Our five-strain Adult Formula CP-1 capsules have a total bacterial
count of at least 35 billion microorganisms per capsule at
date of expiration. The count at date of manufacture can exceed
78 billion bacteria per capsule. This is independently verified
by certified laboratory analysis. Upon request, we will be
pleased to share with you the most recent independent laboratory
test results, that indicated 69 billion per capsule.
Adult Formula CP-1's high bacterial count, broad-spectrum
formulation and high viability of friendly bacteria all contribute
to its effectiveness. It is dairy free, hypoallergenic, and
does not contain any artificial colours, flavours, preservatives,
sugar, gluten or FOS. Our custom probiotic powder formulations
range from 100 to 300 billion micro-organisms per gram, the
highest potency of any probiotic formulation available in
the market today.
We do not use prebiotics, such as fructooligosacharides (F0S)
or inulin, in our formulations, with a view to eliminating
possible adverse reactions by highly allergic and sensitive
individuals, such as those suffering from Candida or inflammatory
bowel disease (IBD) patients. Most FOS in today’s market
contains 5-40% free sugar. We suggest getting FOS from vegetables
such as onion, garlic, asparagus, dandelion, artichokes and
leeks, which have many additional health promoting and nutritional
benefits.
DOSAGE
Growth characteristics of probiotics appear to be species-specific
and depend on the amount ingested and duration of administration.
The greater the bacterial imbalance in the digestive system,
the higher the dosage required for positive and measurable
results.
Dosage differs from individual to individual. You must find
the appropriate dosage for you, which may be 1, 2 or 6 of
our Adult Formula CP-1 capsules per day. We suggest gradually
increasing the probiotic dosage from one capsule to a maximum
of six capsules per day to find the appropriate dosage. Like
a fingerprint, the composition of the intestinal microflora
is quite different from one human to another, which is an
immediate obstacle in manipulating it. Hence the appropriate
dosage of probiotics needs to be determined individually.
How you use a probiotic depends on why you are taking it.
If the primary purpose for taking the probiotic is to aid
digestion, then you must take it with meals. If the goal is
to have the probiotic reach the lower intestinal tract, then
it may be more appropriate to take it between meals, with
a large glass of tepid water. Water dilutes the stomach acids
and moves the organisms quickly into the intestinal tract.
Probiotics can also be used for both purposes by taking some
with meals and some between meals. We suggest taking probiotics
first thing in the morning and at bedtime, with water.
There will, inevitably, be some loss of activity of probiotics
during the passage from stomach to colon, due to pH, bile
acids and other factors. Successful colonization depends very
much on optimal dosing and can be very strain dependent. That
is the reason a high potency multi-strain formulation such
as our Adult Formula CP-1 and probiotic powders become effective.
The gastrointestinal tract harbours about 100 trillion bacteria,
more than 90% in the colon. The intake of merely a few billion
probiotic ‘friendly bacteria’ a day is unlikely
to make much of a difference in most instances. Also please
note that our probiotic strains are very much acid resistant.
OUR PRODUCTS SHOULD BE REFRIGERATED TO RETAIN MAXIMUM POTENCY.
Keeping our product at room temperature for 2-3 weeks, however,
will have little impact on the bacterial count. We have studied
the effect of temperature on our CP-1 capsules. Storing one
bottle in an non airconditioned room, in the Californian summer,
for five months, resulted in bacterial count reduction from
60 billion cfu's per capsule to 30 billion cfu's per capsule,
indicating very good temperature stability of our probiotics.
For further information, comments or ordering of our
QUALITY probiotic dietary supplements please review
our informative web site, and do not hesitate to Contact Us
by phone, fax, e-mail or online
store.
|